Using molecular and immunological methods, such as quantitative RT–PCR, immunochistochemistry and Western blot, we have clearly proved pendrin protein expression in a wide spectrum of both normal and pathological tissues, mainly tumours. This evidence concerns the gene SLC26A4 and neoplasm.